Online Impact
Statistics from Altmetric.com
ARTICLE USAGE
Cited By
Article Information
Volume 5, Issue 8, pp. 850-859
PubMed
Published By
Print ISSN
Online ISSN
History
- Received March 11, 2015
- Revision received May 7, 2015
- Accepted May 11, 2015
- Published first May 13, 2015.
Article Versions
- Previous version (May 13, 2015 - 06:52).
- Previous version (June 24, 2015 - 07:12).
- Previous version (July 17, 2015 - 10:42).
- You are viewing the most recent version of this article.
Copyright & Usage
©2015 American Association for Cancer Research.
Author Information
- Garrett M. Frampton1,*,
- Siraj M. Ali1,
- Mark Rosenzweig1,
- Juliann Chmielecki1,
- Xinyuan Lu2,
- Todd M. Bauer3,
- Mikhail Akimov4,
- Jose A. Bufill5,
- Carrie Lee6,
- David Jentz7,
- Rick Hoover7,
- Sai-Hong Ignatius Ou8,
- Ravi Salgia9,
- Tim Brennan1,
- Zachary R. Chalmers1,
- Savina Jaeger10,
- Alan Huang10,
- Julia A. Elvin1,
- Rachel Erlich1,
- Alex Fichtenholtz1,
- Kyle A. Gowen1,
- Joel Greenbowe1,
- Adrienne Johnson1,
- Depinder Khaira1,
- Caitlin McMahon1,
- Eric M. Sanford1,
- Steven Roels1,
- Jared White1,
- Joel Greshock10,
- Robert Schlegel10,
- Doron Lipson1,
- Roman Yelensky1,
- Deborah Morosini1,
- Jeffrey S. Ross1,
- Eric Collisson2,
- Malte Peters4,
- Philip J. Stephens1 and
- Vincent A. Miller1
- 1Foundation Medicine Inc., Cambridge, Massachusetts.
- 2Division of Hematology and Oncology, Department of Medicine, University of California, San Francisco, San Francisco, California.
- 3Sarah Cannon Research Institute/Tennessee Oncology, PLLC, Nashville, Tennessee.
- 4Novartis Pharma AG, Basel, Switzerland.
- 5Michiana Hematology-Oncology, PC, Mishawaka, Indiana.
- 6University of North Carolina School of Medicine, Clinical Research, Thoracic Oncology Program, Chapel Hill, North Carolina.
- 7South Bend Medical Foundation, South Bend, Indiana.
- 8Division of Hematology-Oncology, Department of Medicine, University of California Irvine School of Medicine, Irvine, California.
- 9The University of Chicago School of Medicine, Chicago, Illinois.
- 10Novartis Institutes for BioMedical Research, Cambridge, Massachusetts.
- ↵*Corresponding Author:
Garrett M. Frampton, Foundation Medicine Inc., 150 Second Street, Cambridge, MA 02141. Phone: 617-418-2200; Fax: 617-418-2201; E-mail: gframpton{at}foundationmedicine.com
August 2015
Volume 5, Issue 8
Volume 5, Issue 8
Activation of MET via Diverse Exon 14 Splicing Alterations Occurs in Multiple Tumor Types and Confers Clinical Sensitivity to MET Inhibitors
Jump to section
Advertisement